Quick Heal Technologies (QUICKHEAL) Q2 24/25 earnings summary

Executive summary

• Achieved H1 FY25 revenue of ₹143.8 crore, up 10.8%-11% YoY, with 238% EBITDA growth and PAT surging to ₹8.2 crore, driven by strong consumer and enterprise performance.

• Launched AntiFraud.AI, India's first comprehensive B2C fraud prevention solution, expanding into a new market category.

• Maintained market leadership in consumer antivirus with over 30% share and 9 million active devices protected, receiving multiple product accolades and patents.

• Continued profitable growth with a focus on innovation, operational efficiency, and leadership team expansion.

• Diluted EPS reached 1.49-1.53 in H1 FY25, up over 4800% YoY.

Financial highlights

• H1 FY25 revenue: ₹143.8 crore; EBITDA: ₹5.7 crore; PAT: ₹8.2 crore; EPS (basic): ₹1.53.

• Q2 FY25 revenue: ₹73.49 crore, up from Q1 but down YoY; Q2 PAT at ₹4.1 crore.

• Gross margin robust at 97% for H1 FY25; PAT margin improved to 5.7%.

• Cash and cash equivalents at Sep 30, 2024: ₹12.76-12.8 crore; total assets: ₹516.6 crore.

• Market cap reached ₹35,449 Mn as of Sep 30, 2024.

Outlook and guidance

• Focus on profitable growth, long-term value creation, and expanding serviceable market from ₹3,000 crore in FY25 to ₹4,000 crore by FY27.

• Continued investment in R&D, sales/marketing, and AI-driven, cloud-native, and Zero Trust solutions.

• Anticipate further business mix diversification and new product scaling.